跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,958 条关于
“ALK fusion proteins”
全部
19,958
临床试验
14,602
药物
1,454
机构
171
资讯
3,731
6个月前
TRIANA Biomedicines' TRI-611 Receives FDA Fast Track Designation for ALK+ NSCLC Treatment
4个月前
Chugai's Alecensa Receives World's First Tumor-Agnostic Approval for ALK Fusion-Positive Solid Tumors
9天前
FDA Clears HanchorBio's HCB101 Single-Patient Expanded Access Protocol, a First for SIRPα-Fc Fusion Proteins
8年前
Genetic Variants and Their Impact on Clinical Responses to Treatments
去年
Gilteritinib Shows Promise as ALK Inhibitor in Acute Myeloid Leukemia
8个月前
HanchorBio Partners with WuXi Biologics to Accelerate Next-Generation Fusion Protein Development
去年
Nuvalent to Present First Clinical Data for Next-Generation ALK Inhibitor NVL-655 at AACR-NCI-EORTC Symposium
去年
Lorlatinib Shows Impressive 5-Year PFS Results in ALK-Positive Advanced NSCLC
9年前
FDA Approves Fourth ALK Inhibitor for Lung Cancer
7个月前
RET Fusion Targeted Therapies Market Projected for Significant Growth Through 2034
第 1 页,共 374 页
上一页
下一页